RecallDepth
Class II Ongoing

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
December 30, 2025
Posted
January 28, 2026
Recall Number
D-0295-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
22,896 bottles
Firm Location
Pennington, NJ, United States

Reason for Recall

Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.

Distribution

US Nationwide.

Lot / Code Info

Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls